Navigation Links
Accera in Medical News

Experimental Drug Ketasyn(TM) (AC-1202) Treats Alzheimer's as Diabetes of the Brain

...n often appear 10 to 20 years earlier than other AD symptoms, targeting them may allow for earlier treatment of the disease. Based on this hypothesis, accera is developing the AD drug, Ketasyn(TM) (AC-1202), which provides glucose-deprived brain cells with an alternative energy source. Ketasyn is converted ...

A Milky Alternative to Alzheimer Drug

...togenic diet sometimes used for children with severe epilepsy. Manufacturer accera is currently hunting funding for a Phase III study, and exploring different...ned Dr. Lauren Constantini, a former Harvard scientist now with the company accera Inc. that is developing the drug. To stop Alzheimer's brain decay,...
Accera in Medical Technology

Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study

...w and similar between Ketasyn and placebo groups. accera recently completed a Phase IIb clinical trial in A...e for efficacy in cognition and short-term memory. accera plans to initiate a pivotal, Phase III multi-cente...r's disease and Age- Associated Memory Impairment. accera has other small molecule compounds in its product ...

Accera, Inc. to Present Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting

... BROOMFIELD, Colo., April 24, 2007 /PRNewswire/ -- accera Inc. announced today that topline data from its Phase IIb study of its lead compound AC-1202 in Alzheimer's disease (AD) will be presented at the annu...

Accera, Inc. Announces Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting

... BROOMFIELD, Colo., May 01, 2007 /PRNewswire/ -- accera Inc. is presenting topline data today from its Phase IIb study of its lead compound AC-1202 in Alzheimer's disease (AD) at the American Academy of Neu...
Accera in Biological Technology

Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease

BROOMFIELD, Colo., March 2 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) diseases, today launched Axona(TM) in the United States for Alzheimer's disease (AD). Axona is a first-in-class medical food for the clinical dietary...

Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease

...ona addresses the hypometabolism or defective metabolism of glucose that occurs in those areas of the brain that are involved in Alzheimer's disease. accera engages in research, development and commercialization of other clinical applications for Axona. For more information about Accera, please v...

Accera, Inc. Launches Neuera Pharmaceuticals, Inc.

... a wholly owned subsidiary and will be spun out of accera as a stand-alone company after the completion of a $12 million series A financing round. Existing accera investors have already committed to participate in...ompany, and the current small molecule pipeline at accera including the preclinical compounds, AC-0523 and A...

Accera, Inc. to Present at Upcoming Investor Conferences

...d-to-moderate Alzheimer's disease. Dr. Orndorff will provide an overview of accera and its technology pipeline and also provide an update on the successful na...ve, well-tolerated treatments. Through its proprietary scientific platform, accera is developing therapies that address metabolic deficiencies by providing an...

Dr. Thomas Werner Elected to Accera, Inc.'s Board of Directors

... impact patients with neurodegenerative disorders who are in need of effective, well-tolerated therapies. Through its proprietary scientific platform, accera is developing products that address metabolic deficiencies associated with certain neurodegenerative diseases by providing an alternative energy sourc...

Accera, Inc. Sponsors Alzheimer's Association's 2009 ICAD Conference

...f, Ph.D., Accera's founder and CEO. "As a company focused on CNS disorders, accera is committed to improving the care and quality of life of Alzheimer's patie...ive, well-tolerated therapies. Through its proprietary scientific platform, accera is developing products that address metabolic deficiencies associated with ...

Accera, Inc. Completes $35 Million Series C Financing

...estament to the confidence of our investors in the accera organization and the potential of Axona". Wolfga... a new approach to neurodegenerative diseases, and accera is a clear leader. We are pleased to support the c...pies. Through its proprietary scientific platform, accera is developing products that address metabolic defi...

Accera, Inc. Names William T. Poncy Vice President of Commercial Development

... BROOMFIELD, Colo., Oct. 10 /PRNewswire/ -- accera Inc., a privately held biotechnology company focus...Ketasyn's excellent safety and efficacy will allow accera to make a competitive entry into the multi billion... (AD) and age-associated memory impairment (AAMI). accera plans to self-commercialize Ketasyn as a medical f...

Accera, Inc. to Present at the 4th Annual BIO Investor Forum

... BROOMFIELD, Colo., Oct. 4 /PRNewswire/ -- accera Inc., a privately held biotechnology company focused on developing novel dr... October 11 at 11:00 a.m. PDT. Dr. Orndorff will provide an overview of accera and its technology platform as well as a summary of the positive data from ...
Other Tags
(Date:7/31/2015)... ... 2015 , ... Ticket Down is a reliable source for authentic tickets for ... Park. The festival will end on Sunday, August 2nd. , Music ... Lollapalooza. This unique and unbelievably popular festival attracts the best in entertainment from ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... to know in predictive health analytics , Jvion continues to disrupt the ... creates predictive software that targets patient and population level illness to drive prevention ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The 2nd annual ... Park in Downtown Memphis on October 3, 2015. The Ride to Fight On is ... cancer research between Methodist Healthcare, The West Clinic and The University of Tennessee Health ...
(Date:7/31/2015)... , ... July 31, 2015 , ... There’s no better ... even when it comes time to cook the next meal, making July the most ... by practicing best grilling tips and recipes. , Make the next cookout different than ...
(Date:7/31/2015)... ... 31, 2015 , ... Facebook, Twitter, Linkedin and blogs are ... media profiles to better connect with the public. The agency website at ... insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide effortless ways ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/23/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ... "Global Outlook of the Biometrics Industry 2015 " ... The global biometrics market is likely to witness ... owing to the uptake of multiple technologies available. ... enhances the growth of biometrics in existing applications ...
(Date:7/20/2015)... 2015  Acuity Market Intelligence,s latest research "The ... Commerce and Privacy" forecasts that between 2014 and ... be downloaded to smart mobile devices by 2.2 ... is projected to generate more than $67.9 billion ... forecast period.    "Biometrics is at ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
Other Contents